🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Tx-LLM accelerates drug development by optimizing for tasks in every stage of the therapeutic pipeline. Want to explore its potential for your research? We're looking to hear from you and are happy to keep you updated on our progress! shorturl.at/FP4AC

x.com/i/article/1858…

🚨 New paper 🚨 Excited to share new capabilities for AMIE our conversational medical AI Google AI Google DeepMind We advance AMIE beyond diagnosis 🩺 towards treatment 💊 over time w/ guidelines . Dive into 🔗research.google/blog/from-diag… with wonderful co-last author Alan Karthikesalingam !

⚛️ TxGemma is a collection of open models designed to accelerate therapeutic data analysis with the power of @GoogleDeepmind’s Gemma.

Developing new drugs can be notoriously slow, expensive and risky. 🔬 Enter TxGemma: a more general, open and scalable set of AI models to help improve this process for researchers and developers. Find out more → goo.gle/3Y864u7

Introducing TxGemma, a family of open models specifically tailored for health settings, building on top of Gemma and Gemini. developers.googleblog.com/en/introducing…

What if LLMs could “read” & “write” biology? 🤔 Introducing C2S‑Scale—a Yale University + Google AI Google DeepMind collab: we scaled LLMs (up to 27 B!) to analyze & generate single‑cell insights by turning transcriptomes into text 🧬➡️📝 🔗 Blog: research.google/blog/teaching-… 🔗 Preprint: